NIH-funded research R21 grant

Using non-invasive light therapy to improve cognitive function in older adults

Official title: Non-invasive lighting treatment as a novel therapeutic for age-related cognitive decline

Funded at University of California Berkeley · NIH-10843281 · Data updated 2026-11-12

This study is looking at how a special flickering light therapy might help older adults with memory and thinking problems by improving their sleep patterns and brain health.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of California Berkeley
NIH-funded
Lab location1 site (Berkeley, United States)
Project startJune 1, 2023
Project endMarch 31, 2026
Funding year2024
Award (this year)$188,012
NIH project number5R21AG082436-02
Project IDNIH-10843281 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults experiencing cognitive decline or at risk for dementia.

Less likely to help

Patients with stable cognitive function or those who do not experience age-related cognitive decline may not benefit from this research.

What this research studies

This research investigates how non-invasive flickering light therapy can help restore circadian rhythms and improve cognitive function in older adults experiencing age-related cognitive decline. The study focuses on understanding the relationship between disrupted circadian rhythms, blood-brain barrier integrity, and cognitive health. By applying a novel lighting technology that emits flickering gamma light, the researchers aim to enhance brain function and protect against cognitive deterioration. The approach is based on previous findings in animal models and seeks to translate these results to human applications.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic options for preventing or mitigating cognitive decline in older adults.

How similar studies have gone: Previous research has shown promising results using similar light therapy approaches in animal models, but this application in humans is novel.

Where this research is happening

  • University of California Berkeley
    Berkeley, United States
    Active

Researchers

  • Principal investigator: Kriegsfeld, Lance J — University of California Berkeley
  • Study coordinator: Kriegsfeld, Lance J

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.